4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001615774-18-014473
Options or other derivatives
- Chief Innovation Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Carpenter George C IV Chief Innovation Officer | 2018-12-12 | Grant or award · EMPLOYEE STOCK OPTION (right to purchase) | +50,000 | 50,000 | D | ||
Loading xslF345X03/ownership.xml…